389 related articles for article (PubMed ID: 27146342)
1. Osteoblastic differentiation of bone marrow mesenchymal stromal cells in Bruck Syndrome.
Kaneto CM; Lima PS; Zanette DL; Oliveira TY; de Assis Pereira F; Lorenzi JC; Dos Santos JL; Prata KL; Neto JM; de Paula FJ; Silva WA
BMC Med Genet; 2016 May; 17(1):38. PubMed ID: 27146342
[TBL] [Abstract][Full Text] [Related]
2. COL1A1 and miR-29b show lower expression levels during osteoblast differentiation of bone marrow stromal cells from Osteogenesis Imperfecta patients.
Kaneto CM; Lima PS; Zanette DL; Prata KL; Pina Neto JM; de Paula FJ; Silva WA
BMC Med Genet; 2014 Apr; 15():45. PubMed ID: 24767406
[TBL] [Abstract][Full Text] [Related]
3. Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome.
Kelley BP; Malfait F; Bonafe L; Baldridge D; Homan E; Symoens S; Willaert A; Elcioglu N; Van Maldergem L; Verellen-Dumoulin C; Gillerot Y; Napierala D; Krakow D; Beighton P; Superti-Furga A; De Paepe A; Lee B
J Bone Miner Res; 2011 Mar; 26(3):666-72. PubMed ID: 20839288
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2.
Ha-Vinh R; Alanay Y; Bank RA; Campos-Xavier AB; Zankl A; Superti-Furga A; Bonafé L
Am J Med Genet A; 2004 Dec; 131(2):115-20. PubMed ID: 15523624
[TBL] [Abstract][Full Text] [Related]
5. Mutations in PLOD2 cause autosomal-recessive connective tissue disorders within the Bruck syndrome--osteogenesis imperfecta phenotypic spectrum.
Puig-Hervás MT; Temtamy S; Aglan M; Valencia M; Martínez-Glez V; Ballesta-Martínez MJ; López-González V; Ashour AM; Amr K; Pulido V; Guillén-Navarro E; Lapunzina P; Caparrós-Martín JA; Ruiz-Perez VL
Hum Mutat; 2012 Oct; 33(10):1444-9. PubMed ID: 22689593
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of bone marrow mesenchymal stem cells from Osteogenesis Imperfecta patients during osteoblast differentiation.
Kaneto CM; Pereira Lima PS; Prata KL; Dos Santos JL; de Pina Neto JM; Panepucci RA; Noushmehr H; Covas DT; de Paula FJA; Silva WA
Eur J Med Genet; 2017 Jun; 60(6):326-334. PubMed ID: 28396251
[TBL] [Abstract][Full Text] [Related]
7. Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation.
Mumm S; Gottesman GS; Wenkert D; Campeau PM; Nenninger A; Huskey M; Bijanki VN; Veis DJ; Barnes AM; Marini JC; Stolina M; Zhang F; McAlister WH; Whyte MP
Bone; 2020 Jan; 130():115047. PubMed ID: 31472299
[TBL] [Abstract][Full Text] [Related]
8. Mutations in FKBP10 cause both Bruck syndrome and isolated osteogenesis imperfecta in humans.
Shaheen R; Al-Owain M; Faqeih E; Al-Hashmi N; Awaji A; Al-Zayed Z; Alkuraya FS
Am J Med Genet A; 2011 Jun; 155A(6):1448-52. PubMed ID: 21567934
[TBL] [Abstract][Full Text] [Related]
9. Bruck syndrome in 13 new patients: Identification of five novel FKBP10 and PLOD2 variants and further expansion of the phenotypic spectrum.
Otaify GA; Abdel-Hamid MS; Hassib NF; Elhossini RM; Abdel-Ghafar SF; Aglan MS
Am J Med Genet A; 2022 Jun; 188(6):1815-1825. PubMed ID: 35278031
[TBL] [Abstract][Full Text] [Related]
10. Novel Mutations in PLOD2 Cause Rare Bruck Syndrome.
Lv F; Xu X; Song Y; Li L; Asan ; Wang J; Yang H; Wang O; Jiang Y; Xia W; Xing X; Li M
Calcif Tissue Int; 2018 Mar; 102(3):296-309. PubMed ID: 29177700
[TBL] [Abstract][Full Text] [Related]
11. A novel homozygous 5 bp deletion in FKBP10 causes clinically Bruck syndrome in an Indonesian patient.
Setijowati ED; van Dijk FS; Cobben JM; van Rijn RR; Sistermans EA; Faradz SM; Kawiyana S; Pals G
Eur J Med Genet; 2012 Jan; 55(1):17-21. PubMed ID: 22085994
[TBL] [Abstract][Full Text] [Related]
12. Loss of Type I Collagen Telopeptide Lysyl Hydroxylation Causes Musculoskeletal Abnormalities in a Zebrafish Model of Bruck Syndrome.
Gistelinck C; Witten PE; Huysseune A; Symoens S; Malfait F; Larionova D; Simoens P; Dierick M; Van Hoorebeke L; De Paepe A; Kwon RY; Weis M; Eyre DR; Willaert A; Coucke PJ
J Bone Miner Res; 2016 Nov; 31(11):1930-1942. PubMed ID: 27541483
[TBL] [Abstract][Full Text] [Related]
13. New insights on the clinical variability of FKBP10 mutations.
Essawi OH; Tapaneeyaphan P; Symoens S; Gistelinck C C; Malfait F; Eyre DR; Essawi T; Callewaert B; Coucke PJ
Eur J Med Genet; 2020 Sep; 63(9):103980. PubMed ID: 32531462
[TBL] [Abstract][Full Text] [Related]
14. Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen.
Schwarze U; Cundy T; Pyott SM; Christiansen HE; Hegde MR; Bank RA; Pals G; Ankala A; Conneely K; Seaver L; Yandow SM; Raney E; Babovic-Vuksanovic D; Stoler J; Ben-Neriah Z; Segel R; Lieberman S; Siderius L; Al-Aqeel A; Hannibal M; Hudgins L; McPherson E; Clemens M; Sussman MD; Steiner RD; Mahan J; Smith R; Anyane-Yeboa K; Wynn J; Chong K; Uster T; Aftimos S; Sutton VR; Davis EC; Kim LS; Weis MA; Eyre D; Byers PH
Hum Mol Genet; 2013 Jan; 22(1):1-17. PubMed ID: 22949511
[TBL] [Abstract][Full Text] [Related]
15. Expanding the Clinical Spectrum of Phenotypes Caused by Pathogenic Variants in PLOD2.
Leal GF; Nishimura G; Voss U; Bertola DR; Åström E; Svensson J; Yamamoto GL; Hammarsjö A; Horemuzova E; Papadiogannakis N; Iwarsson E; Grigelioniene G; Tham E
J Bone Miner Res; 2018 Apr; 33(4):753-760. PubMed ID: 29178448
[TBL] [Abstract][Full Text] [Related]
16. A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family.
Xia XY; Cui YX; Huang YF; Pan LJ; Yang B; Wang HY; Li XJ; Shi YC; Lu HY; Zhou YC
Clin Chim Acta; 2008 Dec; 398(1-2):148-51. PubMed ID: 18755172
[TBL] [Abstract][Full Text] [Related]
17. Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing.
Liu Y; Asan ; Ma D; Lv F; Xu X; Wang J; Xia W; Jiang Y; Wang O; Xing X; Yu W; Wang J; Sun J; Song L; Zhu Y; Yang H; Wang J; Li M
Osteoporos Int; 2017 Oct; 28(10):2985-2995. PubMed ID: 28725987
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 Japanese patients with osteogenesis imperfecta.
Ohata Y; Takeyari S; Nakano Y; Kitaoka T; Nakayama H; Bizaoui V; Yamamoto K; Miyata K; Yamamoto K; Fujiwara M; Kubota T; Michigami T; Yamamoto K; Yamamoto T; Namba N; Ebina K; Yoshikawa H; Ozono K
Osteoporos Int; 2019 Nov; 30(11):2333-2342. PubMed ID: 31363794
[TBL] [Abstract][Full Text] [Related]
19. Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients.
Ries-Levavi L; Ish-Shalom T; Frydman M; Lev D; Cohen S; Barkai G; Goldman B; Byers P; Friedman E
Hum Mutat; 2004 Apr; 23(4):399-400. PubMed ID: 15024745
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and the identification of novel mutations of COL1A1 and COL1A2 in 61 Chinese patients with osteogenesis imperfecta.
Zhang H; Yue H; Wang C; Hu W; Gu J; He J; Fu W; Hu Y; Li M; Zhang Z
Mol Med Rep; 2016 Nov; 14(5):4918-4926. PubMed ID: 27748872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
